IWG PLC/ JE00BYVQYS01 /
2024-04-26 5:28:30 PM | Chg. +3.10 | Volume | Bid5:30:00 PM | Ask5:30:00 PM | High | Low |
---|---|---|---|---|---|---|
186.50GBX | +1.69% | 91,351 Turnover(GBP): 170,889.0115 |
-Bid Size: - | -Ask Size: - | 188.70 | 184.40 |
GlobeNewswire
03-26
argenx Announces Approval of VYVGART (efgartigimod alfa) in Japan for Adults with Primary Immune Thr...
GlobeNewswire
2023-12-11
Keros Therapeutics Presents Clinical Data from its KER-050 Program at the 65th American Society of H...
GlobeNewswire
2023-11-28
argenx Reports Topline Results from ADVANCE-SC Study of VYVGART Hytrulo in Primary Immune Thrombocyt...
Newsfile Corp
2023-10-05
GoGlobal Announces Partnership with IWG to Offer Office Space and Hybrid Working Solutions to Client...
GlobeNewswire
2021-12-13
Corrected: Keros Therapeutics Presents Clinical Trial and Preclinical Study Results from its KER-050...
GlobeNewswire
2021-12-13
Keros Therapeutics Presents Clinical Trial and Preclinical Study Results from its KER-050 Program an...
GlobeNewswire
2021-11-12
Biosight Announces Initiation of Phase 2 Clinical Trial of Aspacytarabine for MDS and AML
GlobeNewswire
2021-08-09
HUTCHMED and Epizyme Announce Strategic Collaboration to Develop and Commercialize TAZVERIK® (tazeme...
GlobeNewswire
2021-02-25
Teleflex Reports Fourth Quarter and Full Year 2020 Results; Provides 2021 Guidance
GlobeNewswire
2020-12-28
Aprea Therapeutics Announces Results of Primary Endpoint from Phase 3 Trial of Eprenetapopt in TP53 ...
GlobeNewswire
2020-12-06
MacroGenics Presents Flotetuzumab Data in Patients with Refractory Acute Myeloid Leukemia at the 202...
GlobeNewswire
2020-06-12
Aprea Therapeutics Presents Results From French Phase Ib/II Clinical Trial of APR-246 (Eprenetapopt)...
GlobeNewswire
2020-04-27
MacroGenics Announces Presentation of Flotetuzumab Translational Data at the 2020 AACR Annual Meetin...
GlobeNewswire
2020-02-20
Teleflex Reports Fourth Quarter and Full Year 2019 Results; Provides 2020 Guidance
GlobeNewswire
2019-12-12
Recap and Update of Positive Data from Phase Ib/II Clinical Trials of APR-246 and Azacitidine (AZA) ...
GlobeNewswire
2019-12-10
Stemline Therapeutics Recaps ELZONRIS Clinical Data Presentations in Patients with Myelofibrosis (or...